MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$98,054K
Short-term marketable
securities
$19,928K
Prepaid expenses and
other current assets
$827K
Total current assets
$118,809K
Operating lease
right-of-use assets
$1,475K
Other non-current
assets
$953K
Restricted cash
$499K
Total assets
$121,736K
Total liabilities,
redeemable convertible...
$121,736K
Total stockholders'
equity (deficit)
$78,814K
Total liabilities
$42,922K
Accumulated deficit
-$159,999K
Additional paid-in capital
$238,805K
Royalty obligation -
related party
$32,076K
Total current
liabilities
$9,714K
Operating lease
liabilities, long-term
$1,132K
Accumulated other
comprehensive income
$6K
Common stock, 0.0001
and 0.00001 par...
$2K
Accrued expenses and
other current...
$8,117K
Accounts payable
$1,281K
Operating lease
liabilities, current
$316K
Back
Back
Balance Sheet
source: myfinsight.com
Kalaris Therapeutics, Inc. (KLRS)
Kalaris Therapeutics, Inc. (KLRS)